» Articles » PMID: 15296653

Colony-stimulating Factor-1 Promotes Clonogenic Growth of Normal Murine Colonic Crypt Epithelial Cells in Vitro

Overview
Publisher Mary Ann Liebert
Date 2004 Aug 7
PMID 15296653
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The intestinal epithelium is a continuously renewing tissue. In the colon, stem cells are maintained at the base of highly organized crypts, where they undergo asymmetric division and give rise to daughter cells that proliferate and migrate up the crypt as they differentiate, then become senescent and are finally shed into the intestinal lumen. The growth factor requirements of fetal and prenatal colon cells for colony formation and that influence the establishment of cell lines from Immorto-mouse (Charles River, Wilmington, MA) transgenic embryos were explored. Single cell suspensions were isolated and cultured in a large range of growth factor combinations and conditions to determine their growth properties in soft agar. We report an important advance in the culture of mouse colonocytes by using macrophage colony-stimulating factor (CSF-1) and granulocyte-macrophage colony-stimulating factor (GM-CSF). A substantial proportion of colonies grown under low oxygen tension in the presence of CSF-1 and GM-CSF express intestinal epithelial A33 antigen, have the expected gene expression profile, including c-fms and transcription factor c-myb, and show an appropriate epithelial cell morphology and undetectable CD45. Confocal microscopy on isolated crypts displays basolateral expression of c-Fms and E-cadherin on most epithelial cells. Fetal colon cultures from the Immorto-mouse with CSF-1 produced rapid outgrowth and readily established cell lines, in contrast to cultures without CSF-1. These observations have implications for the understanding of colon epithelial development and recovery following cytotoxic damage as well as providing a basis for the observation that some colon (and other epithelial) tumor cells respond to CSF-1 and GM-CSF.

Citing Articles

ST2 and CSF-1 as potential druggable targets of inflammatory bowel diseases: Results from two-sample Mendelian randomization study.

Mi J, Wu X, Bai X, Yang Y, Yang H Clin Transl Sci. 2022; 16(2):236-245.

PMID: 36333983 PMC: 9926074. DOI: 10.1111/cts.13442.


A Novel Probiotic Strain Confers Cytoprotection to Host Pig Intestinal Epithelial Cells during Enterotoxic Infection.

Sudan S, Zhan X, Li J Microbiol Spectr. 2022; 10(4):e0125721.

PMID: 35736372 PMC: 9430607. DOI: 10.1128/spectrum.01257-21.


Interleukin-34 Mediates Cross-Talk Between Stromal Cells and Immune Cells in the Gut.

Monteleone G, Franze E, Troncone E, Maresca C, Marafini I Front Immunol. 2022; 13:873332.

PMID: 35529879 PMC: 9073079. DOI: 10.3389/fimmu.2022.873332.


A platform of genetically engineered bacteria as vehicles for localized delivery of therapeutics: Toward applications for Crohn's disease.

McKay R, Ghodasra M, Schardt J, Quan D, Pottash A, Shang W Bioeng Transl Med. 2018; 3(3):209-221.

PMID: 30377661 PMC: 6195910. DOI: 10.1002/btm2.10113.


Prodrugs for colon-restricted delivery: Design, synthesis, and in vivo evaluation of colony stimulating factor 1 receptor (CSF1R) inhibitors.

George D, Huntley R, Cusack K, Duignan D, Hoemann M, Loud J PLoS One. 2018; 13(9):e0203567.

PMID: 30192846 PMC: 6128612. DOI: 10.1371/journal.pone.0203567.